Literature DB >> 1667868

Presynaptic modulation of neurotransmitter release by endogenous angiotensin II in brown adipose tissue.

L A Cassis1, L P Dwoskin.   

Abstract

Angiotensin II (AII) increased the evoked release of [3H]-norepinephrine (NE) from superfused slices of interscapular fat (ISF). To determine if AII was endogenously formed and subsequently released from ISF, immunoreactive AII was measured in the superfusate from ISF slices. The concentration of AII detected in the ISF superfusate was 4.51 pg/mg tissue wet wt/30 ml collected over a 30-min period. In response to electrical field stimulation, AII concentration in the superfusate increased (maximum of 2-fold). To determine if AII modulates sympathetic neurotransmission, the effect of AII (0.1-10 nM) and, in separate experiments the effect of the AII-1 receptor antagonist DuP 753 (1 nM-1 microM) on the evoked release of [3H]-NE were examined in ISF slices. AII and DuP 753 increased (100% above control) and decreased (43% of control), respectively, the evoked [3H]-NE release from ISF slices. The effect of DuP 753 was not altered by the inclusion of neuronal uptake inhibitors (nomifensine or desipramine) in the superfusion buffer. These results suggest that endogenous AII enhances the evoked release of [3H]-NE from ISF.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1667868     DOI: 10.1007/978-3-7091-9175-0_17

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  8 in total

1.  Angiotensin AT1 and AT2 receptor antagonists modulate nicotine-evoked [³H]dopamine and [³H]norepinephrine release.

Authors:  Vidya Narayanaswami; Sucharita S Somkuwar; David B Horton; Lisa A Cassis; Linda P Dwoskin
Journal:  Biochem Pharmacol       Date:  2013-07-04       Impact factor: 5.858

2.  Multiple prejunctional actions of angiotensin II on noradrenergic transmission in the caudal artery of the rat.

Authors:  S L Cox; D F Story; J Ziogas
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 3.  The renin angiotensin system and the metabolic syndrome.

Authors:  Annette D de Kloet; Eric G Krause; Stephen C Woods
Journal:  Physiol Behav       Date:  2010-04-08

4.  Central angiotensin II has catabolic action at white and brown adipose tissue.

Authors:  Annette D de Kloet; Eric G Krause; Karen A Scott; Michelle T Foster; James P Herman; Randall R Sakai; Randy J Seeley; Stephen C Woods
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-08-23       Impact factor: 4.310

Review 5.  Metabolic rate regulation by the renin-angiotensin system: brain vs. body.

Authors:  Justin L Grobe; Kamal Rahmouni; Xuebo Liu; Curt D Sigmund
Journal:  Pflugers Arch       Date:  2012-04-12       Impact factor: 3.657

Review 6.  Neuroimmune communication in hypertension and obesity: a new therapeutic angle?

Authors:  Annette D de Kloet; Eric G Krause; Peng D Shi; Jasenka Zubcevic; Mohan K Raizada; Colin Sumners
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

7.  Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice.

Authors:  Frederique Yiannikouris; Manisha Gupte; Kelly Putnam; Sean Thatcher; Richard Charnigo; Debra L Rateri; Alan Daugherty; Lisa A Cassis
Journal:  Hypertension       Date:  2012-10-29       Impact factor: 10.190

8.  Acute and chronic losartan administration: effect on angiotensin II content and modulation of [3H]norepinephrine release from rat interscapular brown adipose tissue.

Authors:  L A Cassis; L P Dwoskin
Journal:  J Neural Transm Gen Sect       Date:  1994
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.